Jennifer E. Cook insider trades

Open-market stock purchases and sales by Jennifer E. Cook, Director at Jazz Pharmaceuticals plc, from SEC Form 4 filings since Nov 6, 2018.

Recent trades

DateStockTradeValue
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$3.4K
Aug 31, 2026JAZZ Jazz Pharmaceuticals plcSold (not open market)$408K
Aug 5, 2026JAZZ Jazz Pharmaceuticals plcBought (not open market)—
Jun 24, 2026BBIO BridgeBio Pharma, IncSold$2.6M
Jun 24, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 24, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 23, 2026BBIO BridgeBio Pharma, IncSold$151K
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 15, 2026BBIO BridgeBio Pharma, IncSold$5.9M
Jun 15, 2026BBIO BridgeBio Pharma, IncSold$101K
Jun 15, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 15, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 3, 2026DNLI Denali Therapeutics IncBought (not open market)—
Jun 3, 2026DNLI Denali Therapeutics IncBought (not open market)—

Companies traded

  • JAZZ Jazz Pharmaceuticals plc: 5 sales, last Aug 31, 2026
  • BBIO BridgeBio Pharma, Inc: 4 sales, last Jun 24, 2026
  • DNLI Denali Therapeutics Inc: 1 sale, last Jun 3, 2026

Get free alerts when Jennifer E. Cook files a new trade →